Tandem Diabetes Care, Inc.TNDMNASDAQ
LOADING
|||
Net Income Growth Trend
Above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
59.61%
↑ 113% above average
Average (39q)
-476.02%
Historical baseline
Range
High:280.70%
Low:-17392.19%
CAGR
+1.1%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | 59.61% |
| Q2 2025 | 59.86% |
| Q1 2025 | -17392.19% |
| Q4 2024 | 103.25% |
| Q3 2024 | 24.54% |
| Q2 2024 | 27.86% |
| Q1 2024 | -42.37% |
| Q4 2023 | 8.98% |
| Q3 2023 | 7.87% |
| Q2 2023 | 71.12% |
| Q1 2023 | -681.39% |
| Q4 2022 | 67.63% |
| Q3 2022 | -225.25% |
| Q2 2022 | -2.32% |
| Q1 2022 | -236.15% |
| Q4 2021 | 86.54% |
| Q3 2021 | 44.56% |
| Q2 2021 | 179.46% |
| Q1 2021 | -129.67% |
| Q4 2020 | 280.70% |
| Q3 2020 | 65.29% |
| Q2 2020 | -82.33% |
| Q1 2020 | -660.60% |
| Q4 2019 | 191.42% |
| Q3 2019 | -91.87% |
| Q2 2019 | 93.42% |
| Q1 2019 | -723.77% |
| Q4 2018 | 110.76% |
| Q3 2018 | 42.31% |
| Q2 2018 | -81.56% |
| Q1 2018 | -186.65% |
| Q4 2017 | 28.87% |
| Q3 2017 | 26.44% |
| Q2 2017 | 8.37% |
| Q1 2017 | -60.52% |
| Q4 2016 | 50.29% |
| Q3 2016 | -62.70% |
| Q2 2016 | 10.54% |
| Q1 2016 | -69.40% |
| Q4 2015 | 38.26% |